2023 Q2 Form 10-Q Financial Statement

#000095017023017950 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $61.26M $56.12M $42.65M
YoY Change 40.42% 31.58%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.061M $2.041M $2.257M
YoY Change -9.96% -9.57% 12.85%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $21.83M $17.01M $3.363M
YoY Change 437.88% 405.89% -17.02%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $12.95M $14.85M $19.26M
YoY Change -23.56% -22.93% -0.42%
Income Tax $1.495M $2.524M $3.614M
% Of Pretax Income 11.54% 17.0% 18.76%
Net Earnings $11.46M $12.32M $15.65M
YoY Change -24.92% -21.26% 3.81%
Net Earnings / Revenue 18.7% 21.96% 36.69%
Basic Earnings Per Share $0.74 $0.78 $0.94
Diluted Earnings Per Share $0.74 $0.77 $0.93
COMMON SHARES
Basic Shares Outstanding 15.48M 15.86M 16.65M
Diluted Shares Outstanding 15.55M 16.03M 16.87M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $278.1M $250.4M $90.05M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $106.2M $104.8M $109.0M
YoY Change 4.91% -3.84% 16.18%
Goodwill $53.10M $53.10M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $5.095B $5.157B $5.079B
YoY Change 1.85% 1.54% 21.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.47M $32.45M $29.65M
YoY Change 8.04% 9.43% 69.42%
Accrued Expenses $4.912M $5.062M $5.773M
YoY Change -13.35% -12.32% 64.94%
Deferred Revenue
YoY Change
Short-Term Debt $44.77M $45.10M $48.20M
YoY Change -15.13% -6.43% 19.6%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $79.24M $77.54M $35.42M
YoY Change 110.89% 118.91% 68.68%
LONG-TERM LIABILITIES
Long-Term Debt $96.65M $96.52M $96.01M
YoY Change 0.54% 0.53% 9.35%
Other Long-Term Liabilities $29.61M $19.37M $17.31M
YoY Change 87.24% 11.93% 253.2%
Total Long-Term Liabilities $126.3M $115.9M $113.3M
YoY Change 12.79% 2.27% 22.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $79.24M $77.54M $35.42M
Total Long-Term Liabilities $126.3M $115.9M $113.3M
Total Liabilities $4.676B $4.732B $4.627B
YoY Change 2.24% 2.27% 21.8%
SHAREHOLDERS EQUITY
Retained Earnings $160.7M $150.8M
YoY Change 37.86%
Common Stock $487.4M $486.9M
YoY Change 1.32%
Preferred Stock
YoY Change
Treasury Stock (at cost) $119.5M $111.3M
YoY Change 29.69%
Treasury Stock Shares
Shareholders Equity $418.4M $425.1M $452.0M
YoY Change
Total Liabilities & Shareholders Equity $5.095B $5.157B $5.079B
YoY Change 1.85% 1.54% 21.03%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $11.46M $12.32M $15.65M
YoY Change -24.92% -21.26% 3.81%
Depreciation, Depletion And Amortization $2.061M $2.041M $2.257M
YoY Change -9.96% -9.57% 12.85%
Cash From Operating Activities $19.33M $19.13M $7.804M
YoY Change -45.3% 145.16% -67.11%
INVESTING ACTIVITIES
Capital Expenditures $2.503M $4.408M -$309.0K
YoY Change -706.05% -1526.54% -116.09%
Acquisitions
YoY Change
Other Investing Activities $90.00M -$13.84M -$165.6M
YoY Change -1425.48% -91.65% -52.82%
Cash From Investing Activities $87.50M -$18.24M -$165.9M
YoY Change -1314.73% -89.0% -52.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -79.09M 145.1M -11.80M
YoY Change 441.9% -1329.65% -106.37%
NET CHANGE
Cash From Operating Activities 19.33M 19.13M 7.804M
Cash From Investing Activities 87.50M -18.24M -165.9M
Cash From Financing Activities -79.09M 145.1M -11.80M
Net Change In Cash 27.73M 145.9M 7.804M
YoY Change 104.91% 1770.04% -105.42%
FREE CASH FLOW
Cash From Operating Activities $19.33M $19.13M $7.804M
Capital Expenditures $2.503M $4.408M -$309.0K
Free Cash Flow $16.82M $14.72M $8.113M
YoY Change -52.93% 81.49% -62.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001227500
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-37624
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
EQUITY BANCSHARES, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
KS
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
72-1532188
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
7701 East Kellogg Drive
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Wichita
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
KS
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
67207
CY2023Q1 dei City Area Code
CityAreaCode
316
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
612.6000
CY2023Q1 dei Security12b Title
Security12bTitle
Class A, Common Stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
EQBK
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15480961
CY2023Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
249982000
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
104013000
CY2023Q1 us-gaap Federal Funds Sold
FederalFundsSold
384000
CY2022Q4 us-gaap Federal Funds Sold
FederalFundsSold
415000
CY2023Q1 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
250366000
CY2022Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
104428000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1183247000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1184390000
CY2023Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
1995000
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
1973000
CY2023Q1 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent
1944000
CY2022Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent
1948000
CY2023Q1 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
648000
CY2022Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
349000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
45103000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
45847000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
3285515000
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
3265701000
CY2023Q1 us-gaap Other Real Estate And Foreclosed Assets
OtherRealEstateAndForeclosedAssets
4171000
CY2022Q4 us-gaap Other Real Estate And Foreclosed Assets
OtherRealEstateAndForeclosedAssets
4409000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
104789000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101492000
CY2023Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
122971000
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
123176000
CY2023Q1 us-gaap Federal Home Loan Bank Stock And Federal Reserve Bank Stock
FederalHomeLoanBankStockAndFederalReserveBankStock
33359000
CY2022Q4 us-gaap Federal Home Loan Bank Stock And Federal Reserve Bank Stock
FederalHomeLoanBankStockAndFederalReserveBankStock
21695000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
20461000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
20630000
CY2023Q1 us-gaap Goodwill
Goodwill
53101000
CY2022Q4 us-gaap Goodwill
Goodwill
53101000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9678000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10596000
CY2023Q1 us-gaap Other Assets
OtherAssets
86466000
CY2022Q4 us-gaap Other Assets
OtherAssets
89736000
CY2023Q1 us-gaap Assets
Assets
5156716000
CY2022Q4 us-gaap Assets
Assets
4981651000
CY2023Q1 us-gaap Demand Deposit Accounts
DemandDepositAccounts
1012671000
CY2022Q4 us-gaap Demand Deposit Accounts
DemandDepositAccounts
1097899000
CY2023Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
1012671000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
1097899000
CY2023Q1 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
2334463000
CY2022Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
2329584000
CY2023Q1 us-gaap Time Deposits
TimeDeposits
939799000
CY2022Q4 us-gaap Time Deposits
TimeDeposits
814324000
CY2023Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
3274262000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
3143908000
CY2023Q1 us-gaap Deposits
Deposits
4286933000
CY2022Q4 us-gaap Deposits
Deposits
4241807000
CY2023Q1 us-gaap Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
45098000
CY2022Q4 us-gaap Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
46478000
CY2023Q1 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
111222000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
138864000
CY2023Q1 us-gaap Loans Payable To Bank
LoansPayableToBank
140000000
CY2023Q1 us-gaap Subordinated Debt
SubordinatedDebt
96522000
CY2022Q4 us-gaap Subordinated Debt
SubordinatedDebt
96392000
CY2023Q1 us-gaap Contractual Obligation
ContractualObligation
19372000
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
15218000
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
32446000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
32834000
CY2023Q1 us-gaap Liabilities
Liabilities
4731593000
CY2022Q4 us-gaap Liabilities
Liabilities
4571593000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
206000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
205000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
486658000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
484989000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
150810000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
140095000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-101238000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-113511000
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
111313000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
101720000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
425123000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
410058000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5156716000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4981651000
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
48381000
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
36306000
CY2023Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
5947000
CY2022Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
5391000
CY2023Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
669000
CY2022Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
655000
CY2023Q1 us-gaap Interest Income Federal Funds Sold And Securities Purchased Under Agreements To Resell
InterestIncomeFederalFundsSoldAndSecuritiesPurchasedUnderAgreementsToResell
1126000
CY2022Q1 us-gaap Interest Income Federal Funds Sold And Securities Purchased Under Agreements To Resell
InterestIncomeFederalFundsSoldAndSecuritiesPurchasedUnderAgreementsToResell
300000
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
56123000
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
42652000
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
13821000
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1722000
CY2023Q1 us-gaap Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
195000
CY2022Q1 us-gaap Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
33000
CY2023Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
1018000
CY2022Q1 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm
9000
CY2023Q1 eqbk Interest Expense Federal Reserve Bank Borrowings
InterestExpenseFederalReserveBankBorrowings
135000
CY2023Q1 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
1844000
CY2022Q1 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
1599000
CY2023Q1 us-gaap Interest Expense
InterestExpense
17013000
CY2022Q1 us-gaap Interest Expense
InterestExpense
3363000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
39110000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
39289000
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-366000
CY2022Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-412000
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
39476000
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
39701000
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1583000
CY2022Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
865000
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
32000
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
40000
CY2023Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
2287000
CY2022Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
2405000
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
9089000
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
9022000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
16692000
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
15068000
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
2879000
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
3170000
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
3916000
CY2022Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
3769000
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
1384000
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
1171000
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1159000
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
976000
CY2023Q1 us-gaap Communication
Communication
485000
CY2022Q1 us-gaap Communication
Communication
470000
CY2023Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
360000
CY2022Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
180000
CY2023Q1 us-gaap Postage Expense
PostageExpense
458000
CY2022Q1 us-gaap Postage Expense
PostageExpense
423000
CY2023Q1 eqbk Free Nationwide Atm Cost
FreeNationwideATMCost
525000
CY2022Q1 eqbk Free Nationwide Atm Cost
FreeNationwideATMCost
501000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
918000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1050000
CY2023Q1 us-gaap Loan Processing Fee
LoanProcessingFee
117000
CY2022Q1 us-gaap Loan Processing Fee
LoanProcessingFee
185000
CY2023Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
-119000
CY2022Q1 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
1000
CY2022Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
323000
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
4706000
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2174000
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
33718000
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
29459000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14847000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19264000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2524000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3614000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12323000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15650000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.94
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.93
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12323000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
15650000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
16018000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-69339000
CY2022Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
79000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
799000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
598000
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
16817000
CY2022Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-68820000
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
4544000
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-17032000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12273000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-51788000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24596000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36138000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
500631000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
15650000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-51788000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.08
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1318000
CY2022Q1 eqbk Restricted Stock Units Dividend Declared Per Share
RestrictedStockUnitsDividendDeclaredPerShare
0.08
CY2022Q1 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
24000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
804000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
50000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
391000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
12381000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
452015000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
410058000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12323000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12273000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1573000
CY2023Q1 eqbk Restricted Stock Units Dividend Declared Per Share
RestrictedStockUnitsDividendDeclaredPerShare
0.10
CY2023Q1 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
35000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1212000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
458000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9593000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
425123000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12323000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
15650000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1212000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
804000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1087000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1172000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
166000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
175000
CY2023Q1 eqbk Amortization Of Cloud Computing Implementation Costs
AmortizationOfCloudComputingImplementationCosts
47000
CY2022Q1 eqbk Amortization Of Cloud Computing Implementation Costs
AmortizationOfCloudComputingImplementationCosts
47000
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-366000
CY2022Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-412000
CY2023Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
163000
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1430000
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1172000
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1926000
CY2023Q1 eqbk Amortization Of Intangibles
AmortizationOfIntangibles
954000
CY2022Q1 eqbk Amortization Of Intangibles
AmortizationOfIntangibles
1085000
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-255000
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-226000
CY2023Q1 eqbk Increase Decrease In Federal Home Loan Bank Stock Dividends
IncreaseDecreaseInFederalHomeLoanBankStockDividends
-140000
CY2022Q1 eqbk Increase Decrease In Federal Home Loan Bank Stock Dividends
IncreaseDecreaseInFederalHomeLoanBankStockDividends
-18000
CY2023Q1 eqbk Gain Loss On Sales And Valuation Adjustments On Other Real Estate Owned
GainLossOnSalesAndValuationAdjustmentsOnOtherRealEstateOwned
-34000
CY2022Q1 eqbk Gain Loss On Sales And Valuation Adjustments On Other Real Estate Owned
GainLossOnSalesAndValuationAdjustmentsOnOtherRealEstateOwned
172000
CY2022Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
79000
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
32000
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-39000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
15000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
43000
CY2023Q1 eqbk Gain Loss On Foreclosed Assets
GainLossOnForeclosedAssets
3000
CY2022Q1 eqbk Gain Loss On Foreclosed Assets
GainLossOnForeclosedAssets
49000
CY2023Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
62000
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
463000
CY2023Q1 eqbk Originations Of Loans Held For Sale
OriginationsOfLoansHeldForSale
3391000
CY2022Q1 eqbk Originations Of Loans Held For Sale
OriginationsOfLoansHeldForSale
16193000
CY2023Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
3154000
CY2022Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
19295000
CY2023Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
1583000
CY2022Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
865000
CY2023Q1 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-176000
CY2022Q1 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
810000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
262000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
205000
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-169000
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-1125000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4216000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
101000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
694000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-12448000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19132000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7804000
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1840000
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
153850000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
17828000
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
57134000
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
4000
CY2023Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
18019000
CY2022Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
85273000
CY2023Q1 eqbk Payment To Acquire Of Usda Guaranteed Loans
PaymentToAcquireOfUSDAGuaranteedLoans
802000
CY2022Q1 eqbk Payment To Acquire Of Usda Guaranteed Loans
PaymentToAcquireOfUSDAGuaranteedLoans
2293000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4408000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
309000
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
39000
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
50000
CY2023Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
38000
CY2022Q1 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
20063000
CY2023Q1 eqbk Payments For Proceeds From Federal Home Loan Bank Stock And Federal Reserve Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStockAndFederalReserveBankStock
11524000
CY2022Q1 eqbk Payments For Proceeds From Federal Home Loan Bank Stock And Federal Reserve Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStockAndFederalReserveBankStock
2362000
CY2023Q1 eqbk Payments For Proceeds Fro Correspondent And Miscellaneous Other Stock
PaymentsForProceedsFroCorrespondentAndMiscellaneousOtherStock
1526000
CY2023Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
172000
CY2022Q1 us-gaap Proceeds From Sale Of Other Real Estate
ProceedsFromSaleOfOtherRealEstate
205000
CY2023Q1 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
1794000
CY2022Q1 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
723000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18244000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-165912000
CY2023Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
45095000
CY2022Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-40311000
CY2023Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
-1380000
CY2022Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
-7807000
CY2023Q1 eqbk Proceeds From Repayments Of Federal Home Loan Bank Borrowings
ProceedsFromRepaymentsOfFederalHomeLoanBankBorrowings
-127642000
CY2022Q1 eqbk Proceeds From Repayments Of Federal Home Loan Bank Borrowings
ProceedsFromRepaymentsOfFederalHomeLoanBankBorrowings
20000000
CY2023Q1 us-gaap Proceeds From Federal Home Loan Bank Advances
ProceedsFromFederalHomeLoanBankAdvances
466091000
CY2022Q1 us-gaap Proceeds From Federal Home Loan Bank Advances
ProceedsFromFederalHomeLoanBankAdvances
122128000
CY2023Q1 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
366091000
CY2022Q1 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
92128000
CY2023Q1 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
141000000
CY2022Q1 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
1000000
CY2023Q1 eqbk Principal Payments On Federal Reserve Bank Borrowings
PrincipalPaymentsOnFederalReserveBankBorrowings
1000000
CY2022Q1 eqbk Principal Payments On Federal Reserve Bank Borrowings
PrincipalPaymentsOnFederalReserveBankBorrowings
1000000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50000
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
458000
CY2022Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
391000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9593000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12381000
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-246000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-385000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1642000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1353000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
145050000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11796000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
145938000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-169904000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
104428000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
259954000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
250366000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
90050000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
12966000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
4739000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
27000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
82000
CY2023Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
27000
CY2022Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
555000
CY2023Q1 eqbk Other Repossessed Assets Acquired Settlement Loans
OtherRepossessedAssetsAcquiredSettlementLoans
46000
CY2022Q1 eqbk Other Repossessed Assets Acquired Settlement Loans
OtherRepossessedAssetsAcquiredSettlementLoans
20000
CY2023Q1 eqbk Purchase Of Investment In Tax Credit Structures
PurchaseOfInvestmentInTaxCreditStructures
4400000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
734122000
CY2023Q1 us-gaap Mortgage Backed Securities Available For Sale Fair Value Disclosure
MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure
653594000
CY2023Q1 us-gaap Held To Maturity Securities Debt Maturities Without Single Maturity Date Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount
1104000
CY2023Q1 us-gaap Mortgage Backed Securities Held To Maturity Fair Value Disclosure
MortgageBackedSecuritiesHeldToMaturityFairValueDisclosure
1118000
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Some items in prior financial statements were reclassified to conform to the current presentation. Management determined the items reclassified are immaterial to the consolidated financial statements taken as a whole and did not result in a change in equity or net income for the periods reported.</span></p>
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1315258000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
172000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
132183000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1183247000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1332419000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
72000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
148101000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1184390000
CY2023Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
1944000
CY2023Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
51000
CY2023Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
1995000
CY2022Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
1948000
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
25000
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
1973000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
8359000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
8329000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
336533000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
310203000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
170171000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
152150000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
66073000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
58971000
CY2023Q1 us-gaap Held To Maturity Securities Debt Maturities After Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount
840000
CY2023Q1 us-gaap Held To Maturity Securities Debt Maturities After Ten Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue
877000
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1315258000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1183247000
CY2023Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
1944000
CY2023Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
1995000
CY2023Q1 us-gaap Securities Held As Collateral At Fair Value
SecuritiesHeldAsCollateralAtFairValue
795161000
CY2022Q4 us-gaap Securities Held As Collateral At Fair Value
SecuritiesHeldAsCollateralAtFairValue
820751000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
133007000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
4399000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
1020757000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
127785000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1153764000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
132183000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
488446000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
39483000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
681683000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
108618000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1170129000
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
148101000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
409
CY2022Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
3265000
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
115000
CY2022Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
36000
CY2022Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Writedown Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForWritedownOfSecuritiesTax
20000
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
602000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
570000
CY2023Q1 eqbk Accounted For At Amortized Cost Assessed For Impairment
AccountedForAtAmortizedCostAssessedForImpairment
1397000
CY2022Q4 eqbk Accounted For At Amortized Cost Assessed For Impairment
AccountedForAtAmortizedCostAssessedForImpairment
1398000
CY2023Q1 us-gaap Investments
Investments
1999000
CY2022Q4 us-gaap Investments
Investments
1968000
CY2023Q1 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
1807000
CY2022Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
1816000
CY2023Q1 eqbk Accounted For At Hypothetical Liquidation Book Value
AccountedForAtHypotheticalLiquidationBookValue
1440000
CY2022Q4 eqbk Accounted For At Hypothetical Liquidation Book Value
AccountedForAtHypotheticalLiquidationBookValue
980000
CY2023Q1 eqbk Accounted For At Proportional Amortization
AccountedForAtProportionalAmortization
23608000
CY2022Q4 eqbk Accounted For At Proportional Amortization
AccountedForAtProportionalAmortization
19794000
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
26855000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
22590000
CY2023Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
28854000
CY2022Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
24558000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
3330618000
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
3311548000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
45103000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
45847000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
3285515000
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
3265701000
CY2023Q1 eqbk Payment To Acquire Of Usda Guaranteed Loans
PaymentToAcquireOfUSDAGuaranteedLoans
802000
CY2022Q1 eqbk Payment To Acquire Of Usda Guaranteed Loans
PaymentToAcquireOfUSDAGuaranteedLoans
2293000
CY2023Q1 eqbk Unamortized Merger Purchase Accounting Adjustments Balance
UnamortizedMergerPurchaseAccountingAdjustmentsBalance
3314000
CY2023Q1 eqbk Loans Purchased At Discount
LoansPurchasedAtDiscount
273286000
CY2022Q4 eqbk Unamortized Merger Purchase Accounting Adjustments Balance
UnamortizedMergerPurchaseAccountingAdjustmentsBalance
3632000
CY2022Q4 eqbk Loans Purchased At Discount
LoansPurchasedAtDiscount
286538000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
45847000
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-366000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
638000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
260000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
45103000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
48365000
CY2022Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-412000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
534000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
171000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
47590000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
3742000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
41361000
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
45103000
CY2023Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
19350000
CY2023Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3311268000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
3330618000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
4946000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
40901000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
45847000
CY2022Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
20425000
CY2022Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3291123000
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
3311548000
CY2023Q1 eqbk Loans Receivable With No Related Allowance Unpaid Principal Balance
LoansReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
6336000
CY2023Q1 eqbk Loans Receivable With No Related Recorded Investment
LoansReceivableWithNoRelatedRecordedInvestment
2409000
CY2023Q1 eqbk Loans Receivable With Related Allowance Unpaid Principal Balance
LoansReceivableWithRelatedAllowanceUnpaidPrincipalBalance
21509000
CY2023Q1 eqbk Loans Receivable With Related Allowance Recorded Investment
LoansReceivableWithRelatedAllowanceRecordedInvestment
14141000
CY2023Q1 eqbk Loans Receivable Related Allowance
LoansReceivableRelatedAllowance
3080000
CY2023Q1 eqbk Financing Receivable Unpaid Principal Balance
FinancingReceivableUnpaidPrincipalBalance
27845000
CY2023Q1 eqbk Loans Receivable Recorded Investment
LoansReceivableRecordedInvestment
16550000
CY2023Q1 eqbk Loans Receivable Related Allowance
LoansReceivableRelatedAllowance
3080000
CY2022Q4 eqbk Loans Receivable With No Related Allowance Unpaid Principal Balance
LoansReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
4042000
CY2022Q4 eqbk Loans Receivable With No Related Recorded Investment
LoansReceivableWithNoRelatedRecordedInvestment
2474000
CY2022Q4 eqbk Loans Receivable With Related Allowance Unpaid Principal Balance
LoansReceivableWithRelatedAllowanceUnpaidPrincipalBalance
23897000
CY2022Q4 eqbk Loans Receivable With Related Allowance Recorded Investment
LoansReceivableWithRelatedAllowanceRecordedInvestment
15127000
CY2022Q4 eqbk Loans Receivable Related Allowance
LoansReceivableRelatedAllowance
4244000
CY2022Q4 eqbk Financing Receivable Unpaid Principal Balance
FinancingReceivableUnpaidPrincipalBalance
27939000
CY2022Q4 eqbk Loans Receivable Recorded Investment
LoansReceivableRecordedInvestment
17601000
CY2022Q4 eqbk Loans Receivable Related Allowance
LoansReceivableRelatedAllowance
4244000
CY2023Q1 eqbk Impaired Loans Receivable With No Related Allowance Average Recorded Investment
ImpairedLoansReceivableWithNoRelatedAllowanceAverageRecordedInvestment
2441000
CY2022Q1 eqbk Impaired Loans Receivable With No Related Allowance Average Recorded Investment
ImpairedLoansReceivableWithNoRelatedAllowanceAverageRecordedInvestment
3842000
CY2022Q1 eqbk Impaired Loans Receivable With No Related Allowance Interest Income Cash Basis Method
ImpairedLoansReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod
1000
CY2023Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
14634000
CY2023Q1 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod
1000
CY2022Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
21186000
CY2023Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
17075000
CY2023Q1 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
1000
CY2022Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
25028000
CY2022Q1 us-gaap Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
1000
CY2023Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
23000
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
16550000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
3330618000
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
17601000
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
3311548000
CY2023Q1 eqbk Outstanding Commitments On Loans
OutstandingCommitmentsOnLoans
128000
CY2023Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
0
CY2023Q1 us-gaap Gain Loss On Fair Value Hedge Ineffectiveness Net
GainLossOnFairValueHedgeIneffectivenessNet
8000
CY2022Q1 us-gaap Gain Loss On Fair Value Hedge Ineffectiveness Net
GainLossOnFairValueHedgeIneffectivenessNet
38000
CY2023Q1 us-gaap Gain Loss On Cash Flow Hedge Ineffectiveness Net
GainLossOnCashFlowHedgeIneffectivenessNet
0
CY2022Q1 us-gaap Gain Loss On Cash Flow Hedge Ineffectiveness Net
GainLossOnCashFlowHedgeIneffectivenessNet
0
CY2023Q1 eqbk Gain Loss On Derivative Instruments In Hedges At Fair Value Net
GainLossOnDerivativeInstrumentsInHedgesAtFairValueNet
8000
CY2022Q1 eqbk Gain Loss On Derivative Instruments In Hedges At Fair Value Net
GainLossOnDerivativeInstrumentsInHedgesAtFairValueNet
38000
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-3000
CY2022Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
675000
CY2023Q1 eqbk Gain Loss On Derivative Instruments And Hedging Activities Net Pretax
GainLossOnDerivativeInstrumentsAndHedgingActivitiesNetPretax
5000
CY2022Q1 eqbk Gain Loss On Derivative Instruments And Hedging Activities Net Pretax
GainLossOnDerivativeInstrumentsAndHedgingActivitiesNetPretax
713000
CY2023Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
468270000
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
7480000
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
6510000
CY2022Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
363305000
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
8736000
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
8012000
CY2023Q1 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
-2285000
CY2022Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
-2860000
CY2023Q1 eqbk Derivative Asset Netting Adjustment
DerivativeAssetNettingAdjustment
-6043000
CY2023Q1 eqbk Derivative Liability Netting Adjustment
DerivativeLiabilityNettingAdjustment
-6043000
CY2022Q4 eqbk Derivative Asset Netting Adjustment
DerivativeAssetNettingAdjustment
-7336000
CY2022Q4 eqbk Derivative Liability Netting Adjustment
DerivativeLiabilityNettingAdjustment
-7336000
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
1437000
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
2752000
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
1400000
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
3536000
CY2023Q1 us-gaap Hedged Asset Fair Value Hedge
HedgedAssetFairValueHedge
17158000
CY2023Q1 us-gaap Hedged Asset Fair Value Hedge Cumulative Increase Decrease
HedgedAssetFairValueHedgeCumulativeIncreaseDecrease
-2008000
CY2022Q4 us-gaap Hedged Asset Fair Value Hedge
HedgedAssetFairValueHedge
17202000
CY2022Q4 us-gaap Hedged Asset Fair Value Hedge Cumulative Increase Decrease
HedgedAssetFairValueHedgeCumulativeIncreaseDecrease
-2384000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
799000
CY2023Q1 eqbk Gain Loss Recorded In Accumulated Other Comprehensive Income
GainLossRecordedInAccumulatedOtherComprehensiveIncome
593000
CY2023Q1 eqbk Gain Loss On Cash Flow Hedges Recognized In Net Interest Income
GainLossOnCashFlowHedgesRecognizedInNetInterestIncome
-676000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5062000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y1M6D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0232
CY2023Q1 eqbk Non Operating Lease Right Of Use Asset
NonOperatingLeaseRightOfUseAsset
5090000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5256000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
5294000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y2M12D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0232
CY2022Q4 eqbk Non Operating Lease Right Of Use Asset
NonOperatingLeaseRightOfUseAsset
5256000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
196000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
208000
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
14000
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
12000
CY2023Q1 us-gaap Lease Cost
LeaseCost
210000
CY2022Q1 us-gaap Lease Cost
LeaseCost
220000
CY2023Q1 us-gaap Lessor Sales Type Lease Lease Not Yet Commenced Description
LessorSalesTypeLeaseLeaseNotYetCommencedDescription
There were no sale and leaseback transactions, leverage leases, lease transactions with related parties or leases that had not yet commenced during the three months ended March 31, 2023.
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
568000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
550000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
554000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
553000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
553000
CY2023Q1 eqbk Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
3316000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6094000
CY2023Q1 eqbk Lessee Operating Lease Liability Discounted Amount
LesseeOperatingLeaseLiabilityDiscountedAmount
1032000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5062000
CY2023Q1 us-gaap Federal Funds Purchased
FederalFundsPurchased
0
CY2022Q4 us-gaap Federal Funds Purchased
FederalFundsPurchased
0
CY2023Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
45098000
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
46478000
CY2023Q1 eqbk Securities Sold Under Agreements To Repurchase Average Balance Of Agreements Outstanding
SecuritiesSoldUnderAgreementsToRepurchaseAverageBalanceOfAgreementsOutstanding
45932000
CY2022 eqbk Securities Sold Under Agreements To Repurchase Average Balance Of Agreements Outstanding
SecuritiesSoldUnderAgreementsToRepurchaseAverageBalanceOfAgreementsOutstanding
53337000
CY2023Q1 eqbk Short Term Debt Average Interest Rate During Period
ShortTermDebtAverageInterestRateDuringPeriod
0.0133
CY2022 eqbk Short Term Debt Average Interest Rate During Period
ShortTermDebtAverageInterestRateDuringPeriod
0.0042
CY2023Q1 us-gaap Federal Home Loan Bank Advances Activity For Year Maximum Outstanding At Any Month End
FederalHomeLoanBankAdvancesActivityForYearMaximumOutstandingAtAnyMonthEnd
46798000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Activity For Year Maximum Outstanding At Any Month End
FederalHomeLoanBankAdvancesActivityForYearMaximumOutstandingAtAnyMonthEnd
64323000
CY2023Q1 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.0128
CY2022Q4 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.0072
CY2023Q1 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
111222000
CY2022Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
138864000
CY2023Q1 us-gaap Debt Instrument Term
DebtInstrumentTerm
P5Y
CY2023Q1 eqbk Debt Instrument Floating Floor Interest Rate
DebtInstrumentFloatingFloorInterestRate
0.0350
CY2022Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-02-11
CY2022Q1 eqbk Debt Instrument Floating Floor Interest Rate
DebtInstrumentFloatingFloorInterestRate
0.0325
CY2022Q1 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0020
CY2023Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-02-10
CY2023Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
25000000
CY2023Q1 eqbk Debt Instrument Floating Floor Interest Rate
DebtInstrumentFloatingFloorInterestRate
0.0325
CY2023Q1 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.20
CY2023Q1 us-gaap Subordinated Debt
SubordinatedDebt
96522000
CY2022Q4 us-gaap Subordinated Debt
SubordinatedDebt
96392000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
296320000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0
CY2023Q1 eqbk Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
0
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
103352000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
399672000
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
459488
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-101238000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-113511000
CY2023Q1 eqbk Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.065
CY2023Q1 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.08
CY2023Q1 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.10
CY2023Q1 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.05
CY2023Q1 eqbk Capital Conservation Buffer Phase In Rate
CapitalConservationBufferPhaseInRate
0.025
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12323000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
15650000
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
15843147
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
16647851
CY2023Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
15661
CY2022Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
4705
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15858808
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16652556
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.94
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
12323000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
15650000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15858808
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16652556
CY2023Q1 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
110526
CY2022Q1 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
112195
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16028051
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16869152
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.93
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
265490
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
205263
CY2023Q1 eqbk Fair Value Assets And Liabilities Levels Transfers Amount
FairValueAssetsAndLiabilitiesLevelsTransfersAmount
0
CY2022 eqbk Fair Value Assets And Liabilities Levels Transfers Amount
FairValueAssetsAndLiabilitiesLevelsTransfersAmount
0
CY2022Q2 eqbk Number Of Branches Sold
NumberOfBranchesSold
3
CY2022Q4 eqbk Number Of Branches Sold
NumberOfBranchesSold
1

Files In Submission

Name View Source Status
eqbk-20230331_lab.xml Edgar Link unprocessable
eqbk-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0000950170-23-017950-index-headers.html Edgar Link pending
0000950170-23-017950-index.html Edgar Link pending
0000950170-23-017950.txt Edgar Link pending
0000950170-23-017950-xbrl.zip Edgar Link pending
eqbk-20230331.htm Edgar Link pending
eqbk-20230331.xsd Edgar Link pending
eqbk-20230331_def.xml Edgar Link unprocessable
eqbk-ex10_2.htm Edgar Link pending
eqbk-ex31_1.htm Edgar Link pending
eqbk-ex31_2.htm Edgar Link pending
eqbk-ex32_1.htm Edgar Link pending
eqbk-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
eqbk-20230331_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
eqbk-20230331_cal.xml Edgar Link unprocessable